Research Article

Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria

Table 4

Prevalence of sarcopenic obesity in the study cohort () using various sex-specific definitions determined by anthropometric and dual-energy X-ray absorptiometry measurements amongst studies investigating sarcopenic obesity.

VariablesaReferenceFemales ()Males ()
Cut pointPrevalence (%)Cut pointPrevalence (%)

LSTI (kg/m2)Zoico et al., 2004 [27]<5.700NANA
LST by weight × 100 (%)Kim et al., 2009 [28]<30.700<35.710
Zoico et al., 2004 [27] (I) 23.1–26.7
(II) <23.1
0
0
NA
NA
NA
NA
ASM (kg)Batsis et al., 2015 [8]<15.020<19.750
ASMI (kg/m2)bZoico et al., 2004 [27] (I) 4.7–5.6
(II) <4.7
0
0
NA
NA
NA
NA
Kim et al., 2009 [28]<5.140<7.400
Baumgartner et al., 1998 [7], 2004 [37]<5.450<7.260
Newman et al., 2003 [29]<5.670<7.230
Bouchard et al., 2009 [30]<6.290<8.510
Kim et al., 2009 [28]<7.364.9<8.815.9
ASM by weight × 100 (%)Levine & Crimmins, 2012 [31]<19.4323.3<25.7258.8
Oh et al., 2015c [32]<23.484.5<29.6100
ASM by BMI (kg/m2)Batsis et al., 2015 [8]<0.51218.4<0.78947.1
ASM adjusted for height and fat mass (residuals)bNewman et al., 2003 [29]<−1.730<−2.2923.5
ASMI and FMI (phenotype)Prado et al., 2014 [18]HA-LMd12.6HA-LMd17.6
FM : FFM ratioSiervo et al., 2015 [33]≥85th percentile28.2≥85th percentile76.5

Terminology for variables is selected for consistency and may differ from terms used by original authors. bWhere applicable, equivalent cut points derived from the study-specific cohort are listed in the text. cCut points determined from reported sex-specific mean and standard deviation in Oh et al., 2015[32]. dHA-LM: high adiposity (FMI 50–100) and low muscle mass (ASMI 0–49.99) with individual z-scores based upon age, sex, and BMI. LSTI: lean soft tissue index; NA: not applicable; LST: lean soft tissue; ASM: appendicular skeletal muscle mass; BMI: body mass index; ASMI: appendicular skeletal mass index; FMI: fat mass index; FM: fat mass; FFM: fat-free mass.